Danish Myo Technology A/S (DMT) is pleased to announce a strategic partnership with ADInstruments do Brasil. The partnership involves the exclusive distribution of DMT’s myograph and isolated heart systems in Latin America.
Carsten Thorndahl, CEO of DMT, said; “This is another solid step in our journey in strengthening our foundation, and we are excited to be partnering with ADI Brasil. The partnership is a strong fit, leveraging our companies’ respective strengths.
ADI Brasil has a specific in-depth knowledge of the South American landscape. With sales and support being more localized - ADI Brasil will be able to enhance the customer experience.”
Carsten Thorndahl, CEO of DMT, said; “This is another solid step in our journey in strengthening our foundation, and we are excited to be partnering with ADI Brasil. The partnership is a strong fit, leveraging our companies’ respective strengths.
ADI Brasil has a specific in-depth knowledge of the South American landscape. With sales and support being more localized - ADI Brasil will be able to enhance the customer experience.”
About ADI
ADInstruments (ADI) is a world leader in the provision of hardware and software for data acquisition in the life sciences. Their comprehensive, easy-to-use products are highly-cited in scientific journals and used in all of the top 100 colleges and universities in the world. For 30 years, they have been successful in developing quality products and providing great customer service.
ADInstruments (ADI) is a world leader in the provision of hardware and software for data acquisition in the life sciences. Their comprehensive, easy-to-use products are highly-cited in scientific journals and used in all of the top 100 colleges and universities in the world. For 30 years, they have been successful in developing quality products and providing great customer service.
